Novus Biologicals, a leading developer and marketer of Life Sciences products, is pleased to announce its acquisition of San Diego-based Imgenex Corporation. Imgenex is a provider of specialized ...
Bio-Techne said Wednesday it closed on its $60 million cash acquisition of Novus Biologicals, a deal designed to expand the buyer’s antibody business while complementing its operations in developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback